These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3566613)

  • 1. Prevention of clot formation in cat retinal vein by systemic and subconjunctival urokinase.
    Levinger S; Zauberman H; Eldor A; Zelikovitch A; Rosenmann E
    Arch Ophthalmol; 1987 Apr; 105(4):554-8. PubMed ID: 3566613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue plasminogen activator in the treatment of experimental retinal vein occlusion.
    Oncel M; Peyman GA; Khoobehi B
    Retina; 1989; 9(1):1-7. PubMed ID: 2497501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superselective ophthalmic arterial fibrinolysis with urokinase for recent severe central retinal venous occlusion: initial experience.
    Vallée JN; Massin P; Aymard A; Paques M; Herbreteau D; Santiago PY; Losser MR; Gaudric A; Merland JJ
    Radiology; 2000 Jul; 216(1):47-53. PubMed ID: 10887227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D; Stassen JM; Verstraete M
    J Clin Invest; 1983 Feb; 71(2):368-76. PubMed ID: 6681615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion.
    Paques M; Vallée JN; Herbreteau D; Aymart A; Santiago PY; Campinchi-Tardy F; Payen D; Merlan JJ; Gaudric A; Massin P
    Br J Ophthalmol; 2000 Dec; 84(12):1387-91. PubMed ID: 11090479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs.
    Tameesh MK; Lakhanpal RR; Fujii GY; Javaheri M; Shelley TH; D'Anna S; Barnes AC; Margalit E; Farah M; De Juan E; Humayun MS
    Am J Ophthalmol; 2004 Nov; 138(5):829-39. PubMed ID: 15531319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-mediated thrombolysis: a dose-response relationship in cats. Work in progress.
    Hedlund LJ; Carlson JE; Urness M; Bildsoe MC; Yedlicka JW; Castaneda-Zuniga WR; Amplatz K; Hunter DW
    J Vasc Interv Radiol; 1991 Aug; 2(3):349-52. PubMed ID: 1799780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of thrombus formation in vivo using a thrombolytic agent targeted at damaged endothelial cells.
    Underwood MJ; Pringle S; de Bono DP
    Br J Surg; 1992 Sep; 79(9):915-7. PubMed ID: 1422755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medical treatment for experimental retinal vein occlusion--thrombolytic effect of nasaruplase].
    Suzuki Y; Matsumoto M; Katoh C; Mizutani H; Sakuraba T; Yoshimoto H
    Nippon Ganka Gakkai Zasshi; 1996 Jan; 100(1):27-33. PubMed ID: 8644523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated cannulation technique for tissue plasminogen activator injection into peripapillary retinal vein for central retinal vein occlusion.
    van Overdam KA; Missotten T; Spielberg LH
    Acta Ophthalmol; 2015 Dec; 93(8):739-44. PubMed ID: 26310993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beneficial effect of lys-plasminogen upon the thrombolytic efficacy of urokinase in a dog model of peripheral arterial thrombosis.
    Badylak SF; Voytik SL; Henkin J; Burke S; Sasahara AA; Simmons A
    Haemostasis; 1991; 21(5):278-85. PubMed ID: 1806456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfusion of occluded retinal veins in the cat's eye.
    Zauberman H; Levinger S; Burde RM
    Br J Ophthalmol; 1984 Jan; 68(1):58-61. PubMed ID: 6537795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term results of endovascular surgery with tissue plasminogen activator injection for central retinal vein occlusion.
    Ishida M; Abe S; Nakagawa T; Hayashi A
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2135-2140. PubMed ID: 28803326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system. In vitro, in vivo, and clinical studies.
    Mitchel JF; Fram DB; Palme DF; Foster R; Hirst JA; Azrin MA; Bow LM; Eldin AM; Waters DD; McKay RG
    Circulation; 1995 Feb; 91(3):785-93. PubMed ID: 7828307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful fibrinolytic treatment with urokinase six weeks after leg and pelvic vein thrombosis (author's transl)].
    Trübestein G; Etzel F; Sobbe A
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2457-9. PubMed ID: 4448142
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of human recombinant tissue-type plasminogen activator and urokinase in microsurgical thrombolysis in the rat.
    Levy EA; Sadove AM; Eppley BL; Evan AP
    J Reconstr Microsurg; 1991 Jul; 7(3):209-16. PubMed ID: 1909760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rationale of retinal endovascular fibrinolysis in the treatment of retinal vein occlusion: from experimental data to clinical application.
    Pournaras CJ; Petropoulos IK; Pournaras JA; Stangos AN; Gilodi N; Rungger-Brändle E
    Retina; 2012 Sep; 32(8):1566-73. PubMed ID: 22466460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin inhibitory and clot-specific fibrinolytic activities of the urokinase variant, M23 (rscu-PA-40 kDa/Hir).
    Schneider J; Wnendt S; Saunders D; Heinzel-Wieland R; Wilffert B; Steffens G
    Eur J Pharmacol; 1996 Apr; 302(1-3):69-77. PubMed ID: 8790994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reperfusion of occluded branch retinal arteries by transluminal Nd:YAG laser embolysis combined with intravenous thrombolysis of urokinase.
    Chai F; Du S; Zhao X; Wang R
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29162667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of retinal branch vein occlusion].
    Noburo A
    Nippon Ganka Gakkai Zasshi; 2005 Jun; 109(6):315-6. PubMed ID: 16047939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.